T. Rowe Price Associates’s Revolution Healthcare Acquisition Corp. SAIL Units REVHU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,491,865
Closed -$44.1M 3034
2022
Q3
$44.1M Sell
4,491,865
-32,367
-0.7% -$318K 0.01% 686
2022
Q2
$44.4M Sell
4,524,232
-458,036
-9% -$4.5M 0.01% 912
2022
Q1
$49.3M Hold
4,982,268
0.01% 968
2021
Q4
$49.1M Sell
4,982,268
-77,009
-2% -$764K ﹤0.01% 1013
2021
Q3
$49.8M Sell
5,059,277
-2,419
-0% -$24K ﹤0.01% 1012
2021
Q2
$50.8M Sell
5,061,696
-138,304
-3% -$1.4M ﹤0.01% 1023
2021
Q1
$52.3M Buy
+5,200,000
New +$52.2M 0.01% 988

T. Rowe Price Associates's REVHU Position: Q4 2022 in Review

T. Rowe Price Associates sold out of Revolution Healthcare Acquisition Corp. SAIL Units (REVHU) in Q4 2022, closing a stake of 4,491,865 shares — an estimated $44.1M sold.

T. Rowe Price Associates first reported a position in REVHU in Q1 2021 and held it in 7 quarters. The position peaked at $52.3M in Q1 2021. 0 funds tracked by Wall St. Rank hold REVHU as of Q4 2022.

  • T. Rowe Price Associates reported no remaining Revolution Healthcare Acquisition Corp. SAIL Units position as of Q4 2022 after selling out during the quarter.
  • T. Rowe Price Associates sold 4,491,865 Revolution Healthcare Acquisition Corp. SAIL Units shares in Q4 2022, an estimated $44.1M.
  • T. Rowe Price Associates first reported a position in Revolution Healthcare Acquisition Corp. SAIL Units in Q1 2021 and held it in 7 quarters.
  • T. Rowe Price Associates's Revolution Healthcare Acquisition Corp. SAIL Units position peaked at $52.3M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Revolution Healthcare Acquisition Corp. SAIL Units as of Q4 2022.

Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.